0001213900-21-029446.txt : 20210527
0001213900-21-029446.hdr.sgml : 20210527
20210527061501
ACCESSION NUMBER: 0001213900-21-029446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210521
FILED AS OF DATE: 20210527
DATE AS OF CHANGE: 20210527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP
CENTRAL INDEX KEY: 0001810117
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31392
FILM NUMBER: 21968440
BUSINESS ADDRESS:
STREET 1: BOODENHIMER 24
CITY: TEL AVIV
STATE: L3
ZIP: 6200838
BUSINESS PHONE: 00972546444183
MAIL ADDRESS:
STREET 1: BOODENHIMER 24
CITY: TEL AVIV
STATE: L3
ZIP: 6200838
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PLURISTEM THERAPEUTICS INC
CENTRAL INDEX KEY: 0001158780
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 980351734
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: MATAM ADVANCED TECHNOLOGY PARK
STREET 2: BUILDING NO. 5
CITY: HAIFA
STATE: L3
ZIP: 3508409
BUSINESS PHONE: 972-74-710-7171
MAIL ADDRESS:
STREET 1: MATAM ADVANCED TECHNOLOGY PARK
STREET 2: BUILDING NO. 5
CITY: HAIFA
STATE: L3
ZIP: 3508409
FORMER COMPANY:
FORMER CONFORMED NAME: PLURISTEM LIFE SYSTEMS INC
DATE OF NAME CHANGE: 20030701
FORMER COMPANY:
FORMER CONFORMED NAME: AI SOFTWARE INC
DATE OF NAME CHANGE: 20010906
4
1
ownership.xml
X0306
4
2021-05-21
0
0001158780
PLURISTEM THERAPEUTICS INC
PSTI
0001810117
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP
24 BODENHIMER STREET
TEL AVIV,
L3
6200838
ISRAEL
0
0
1
0
Common Stock
2021-05-21
4
S
0
69838
3.98
D
3818026
D
Common Stock
2021-05-24
4
S
0
79300
3.83
D
3738726
D
Common stock
2021-05-25
4
S
0
261238
3.84
D
3477488
D
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.78 to $3.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from approximately $3.65 to $4.14 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Clover Wolf Capital - Limited Partnership By: Clover Wolf Ltd., its General Partner /s/ Adi Wolf, Chief Executive Officer and Managing Member
2021-05-27